Genentech

Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.

Now Approved

The FDA recently granted approval to our treatment for wet age-related macular degeneration, a first-of-its-kind therapeutic approach for this leading cause of blindness.

Learn More

Quick Links
Diversity & Inclusion
Patient Financial Support
Clinical Trial Information
Our Pipeline
Our Medicines
Featured Topics

Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.

Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.

Now Approved